IMSI is most beneficial for patients with repeated IVF or ICSI failures, severe male factor infertility with high levels of abnormal morphology, recurrent pregnancy loss, or consistently poor embryo quality in previous cycles. It is not a routine requirement for all IVF patients and is recommended selectively at Galwa Care Hospital for cases where its unique advantages in precision sperm selection are expected to add the most meaningful clinical benefit. Your specialist will assess your individual profile and advise accordingly.

IMSI can meaningfully improve outcomes in specifically selected cases, particularly those involving severe male morphology issues or repeated treatment failures where standard ICSI selection has not been sufficient. Clinical evidence supports its benefit in these patient groups in terms of fertilization rates and embryo quality. IMSI may also help reduce miscarriage risk in cases where subtle sperm structural or DNA-related defects have been contributing to early pregnancy loss by ensuring only the most structurally sound sperm are used.

No. IMSI is performed entirely in the embryology laboratory and does not involve any additional procedure or discomfort for the patient beyond the standard IVF and ICSI cycle experience. The ultra-high magnification sperm selection step takes additional laboratory time compared to standard ICSI, but the overall treatment cycle timeline remains that of a standard IVF cycle, typically 2 to 3 weeks from ovarian stimulation to the pregnancy test result.

Yes on both counts. Frozen sperm that has been thawed and prepared in the laboratory can be used effectively in IMSI, as the ultra-high magnification selection process works equally well with thawed sperm samples. All surplus good-quality embryos produced during an IMSI cycle can be vitrified and stored securely at Galwa Care Hospital for future frozen embryo transfer cycles, improving the overall cumulative success potential and cost-efficiency of each treatment cycle undertaken.